Aldeyra Therapeutics

ALDXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$93.498 M

$1.55 -2.52%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$33.8M

Loss-making

Shares outstanding

60,326,421

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#306Rani TherapeuticsRANI$98.1M
#307Oncolytics BiotechONCY$95.8M
#308Aldeyra TherapeuticsALDX$93.5M
#309Heron TherapeuticsHRTX$92.9M
#310Biomea FusionBMEA$91.3M

Where these numbers come from

Share counts and financials for Aldeyra Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.